A
$ Value
$0
Shares
27,258
Price
$0
Filed
Apr 2
Insider
Name
Theagene Jean-Manasse
Title
—
CIK
0001969857
Roles
Director
Transaction Details
Transaction Date
2026-03-31
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,258
Footnotes
The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Filing Info
Theagene Jean-Manasse's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | MAIA | A | $0 |
| 2025-12-31 | MAIA | A | $0 |
| 2025-10-02 | MAIA | A | $0 |
| 2025-06-30 | MAIA | A | $0 |
Other Insiders at MAIA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CHAOUKI STEVEN M | — | — | 2026-03-31 |
| Smith Stan | — | — | 2026-03-31 |
|
Gryaznov Sergei
Chief Scientific Officer
|
— | — | 2026-04-10 |
| Guerrero Ramiro | — | — | 2026-03-31 |
|
Vitoc Vlad
Chief Executive Officer
|
— | — | 2026-04-10 |
| Louie Ngar Yee | — | — | 2026-03-31 |
| Luput Cristian | — | — | 2026-03-31 |
|
Himmelreich Jeffrey C
Head of Finance
|
— | — | 2026-04-10 |